Welcome to LookChem.com Sign In|Join Free
  • or
2-Pyridinecarboxylic acid, 3,5-dibroMo-, Methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

61830-41-9

Post Buying Request

61830-41-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61830-41-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61830-41-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,3 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 61830-41:
(7*6)+(6*1)+(5*8)+(4*3)+(3*0)+(2*4)+(1*1)=109
109 % 10 = 9
So 61830-41-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H5Br2NO2/c1-12-7(11)6-5(9)2-4(8)3-10-6/h2-3H,1H3

61830-41-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 3,5-dibromopyridine-2-carboxylate

1.2 Other means of identification

Product number -
Other names 2-Pyridinecarboxylic acid,3,5-dibromo-,methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61830-41-9 SDS

61830-41-9Downstream Products

61830-41-9Relevant academic research and scientific papers

COMBINATION PRODUCT FOR THE TREATMENT OF CANCEROUS DISEASES

-

Page/Page column 132, (2021/12/31)

The present invention relates to a product for combination therapies useful for the treatment of cancer diseases. In particular, the invention relates to the combination of an anti-PD-Ll antibody and an MCT4 inhibitor of Formula (I). The therapeutic combination may be utilized for the use in treating a subject having a cancer disease that tests positive for PD-L1 and/or MCT4 expression.

DISUBSTITUTED ALKYNE DERIVATIVES

-

Page/Page column 125-126, (2020/07/14)

The present invention relates to disubstituted alkyne derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61830-41-9